Morgan Stanley Upgrades Elanco Animal Health to Overweight, Announces $16 Price Target
Morgan Stanley Upgrades Elanco Animal Health to Overweight, Announces $16 Price Target
摩根士丹利將Elanco Animal Health上調至增持，宣佈目標股價爲16美元
Morgan Stanley analyst Erin Wright upgrades Elanco Animal Health (NYSE:ELAN) from Equal-Weight to Overweight and announces $16 price target.
摩根士丹利分析師艾琳·賴特將Elanco Animal Health（紐約證券交易所代碼：ELAN）從等權重上調至增持，並宣佈了16美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。